Citadel Advisors’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
2022
Q2
$12.5M Sell
2022
Q1
$22.2M Buy
2021
Q4
$30.8M Buy
2021
Q3
$16.1M Buy
2021
Q2
$554K Sell
2021
Q1
$9.84M Buy
2020
Q4
$772K Sell
2020
Q3
$8.97M Buy
2020
Q2
$3.31M Buy
2020
Q1
$532K Buy
2019
Q3
Sell
2019
Q2
$1.85M Buy